Manuela Semmler-Behnke1,2, Jens Lipka3, Alexander Wenk4, Stephanie Hirn5,6, Martin Schäffler7, Furong Tian8,9, Günter Schmid10, Günter Oberdörster11, Wolfgang G Kreyling12,13. 1. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. Manuela.Behnke@lgl.bayern.de. 2. Current address: Bavarian Health and Food Safety Authority, 85764, Oberschleissheim, Germany. Manuela.Behnke@lgl.bayern.de. 3. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. j_lipka@gmx.de. 4. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. alexander.wenk@helmholtz-muenchen.de. 5. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. stephanie.hirn@med.uni-muenchen.de. 6. Current address: Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. stephanie.hirn@med.uni-muenchen.de. 7. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. martin.schaeffler@helmholtz-muenchen.de. 8. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. furong.tian@googlemail.com. 9. Current address: Focus Research Institute, Dublin Institute of Technology, Dublin, Ireland. furong.tian@googlemail.com. 10. Institute of Inorganic Chemistry University Duisburg-Essen, 45117, Essen, Germany. guenter.schmid@uni-due.de. 11. Department of Environmental Medicine, University of Rochester, Rochester, New York, USA. Gunter_Oberdorster@urmc.rochester.edu. 12. Institute of Lung Biology and Disease, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. kreyling@helmholtz-muenchen.de. 13. Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764, Neuherberg/Munich, Germany. kreyling@helmholtz-muenchen.de.
Abstract
BACKGROUND: There is evidence that nanoparticles (NP) cross epithelial and endothelial body barriers. We hypothesized that gold (Au) NP, once in the blood circulation of pregnant rats, will cross the placental barrier during pregnancy size-dependently and accumulate in the fetal organism by 1. transcellular transport across the hemochorial placenta, 2. transcellular transport across amniotic membranes 3. transport through ~20 nm wide transtrophoblastic channels in a size dependent manner. The three AuNP sizes used to test this hypothesis are either well below, or of similar size or well above the diameters of the transtrophoblastic channels. METHODS: We intravenously injected monodisperse, negatively charged, radio-labelled 1.4 nm, 18 nm and 80 nm ¹⁹⁸AuNP at a mass dose of 5, 3 and 27 μg/rat, respectively, into pregnant rats on day 18 of gestation and in non-pregnant control rats and studied the biodistribution in a quantitative manner based on the radio-analysis of the stably labelled ¹⁹⁸AuNP after 24 hours. RESULTS: We observed significant biokinetic differences between pregnant and non-pregnant rats. AuNP fractions in the uterus of pregnant rats were at least one order of magnitude higher for each particle size roughly proportional to the enlarged size and weight of the pregnant uterus. All three sizes of ¹⁹⁸AuNP were found in the placentas and amniotic fluids with 1.4 nm AuNP fractions being two orders of magnitude higher than those of the larger AuNP on a mass base. In the fetuses, only fractions of 0.0006 (30 ng) and 0.00004 (0.1 ng) of 1.4 nm and 18 nm AuNP, respectively, were detected, but no 80 nm AuNP (<0.000004 (<0.1 ng)). These data show that no AuNP entered the fetuses from amniotic fluids within 24 hours but indicate that AuNP translocation occurs across the placental tissues either through transtrophoblastic channels and/or via transcellular processes. CONCLUSION: Our data suggest that the translocation of AuNP from maternal blood into the fetus is NP-size dependent which is due to mechanisms involving (1) transport through transtrophoblastic channels - also present in the human placenta - and/or (2) endocytotic and diffusive processes across the placental barrier.
BACKGROUND: There is evidence that nanoparticles (NP) cross epithelial and endothelial body barriers. We hypothesized that gold (Au) NP, once in the blood circulation of pregnant rats, will cross the placental barrier during pregnancy size-dependently and accumulate in the fetal organism by 1. transcellular transport across the hemochorial placenta, 2. transcellular transport across amniotic membranes 3. transport through ~20 nm wide transtrophoblastic channels in a size dependent manner. The three AuNP sizes used to test this hypothesis are either well below, or of similar size or well above the diameters of the transtrophoblastic channels. METHODS: We intravenously injected monodisperse, negatively charged, radio-labelled 1.4 nm, 18 nm and 80 nm ¹⁹⁸AuNP at a mass dose of 5, 3 and 27 μg/rat, respectively, into pregnant rats on day 18 of gestation and in non-pregnant control rats and studied the biodistribution in a quantitative manner based on the radio-analysis of the stably labelled ¹⁹⁸AuNP after 24 hours. RESULTS: We observed significant biokinetic differences between pregnant and non-pregnant rats. AuNP fractions in the uterus of pregnant rats were at least one order of magnitude higher for each particle size roughly proportional to the enlarged size and weight of the pregnant uterus. All three sizes of ¹⁹⁸AuNP were found in the placentas and amniotic fluids with 1.4 nm AuNP fractions being two orders of magnitude higher than those of the larger AuNP on a mass base. In the fetuses, only fractions of 0.0006 (30 ng) and 0.00004 (0.1 ng) of 1.4 nm and 18 nm AuNP, respectively, were detected, but no 80 nm AuNP (<0.000004 (<0.1 ng)). These data show that no AuNP entered the fetuses from amniotic fluids within 24 hours but indicate that AuNP translocation occurs across the placental tissues either through transtrophoblastic channels and/or via transcellular processes. CONCLUSION: Our data suggest that the translocation of AuNP from maternal blood into the fetus is NP-size dependent which is due to mechanisms involving (1) transport through transtrophoblastic channels - also present in the human placenta - and/or (2) endocytotic and diffusive processes across the placental barrier.
Authors: Martin Schäffler; Fernanda Sousa; Alexander Wenk; Leopoldo Sitia; Stephanie Hirn; Carsten Schleh; Nadine Haberl; Martina Violatto; Mara Canovi; Patrizia Andreozzi; Mario Salmona; Paolo Bigini; Wolfgang G Kreyling; Silke Krol Journal: Biomaterials Date: 2014-01-22 Impact factor: 12.479
Authors: W G Kreyling; M Semmler; F Erbe; P Mayer; S Takenaka; H Schulz; G Oberdörster; A Ziesenis Journal: J Toxicol Environ Health A Date: 2002-10-25
Authors: Peter Wick; Antoine Malek; Pius Manser; Danielle Meili; Xenia Maeder-Althaus; Liliane Diener; Pierre-Andre Diener; Andreas Zisch; Harald F Krug; Ursula von Mandach Journal: Environ Health Perspect Date: 2009-11-12 Impact factor: 9.031
Authors: Carolyn Klocke; Joshua L Allen; Marissa Sobolewski; Margot Mayer-Pröschel; Jason L Blum; Dana Lauterstein; Judith T Zelikoff; Deborah A Cory-Slechta Journal: Toxicol Sci Date: 2017-04-01 Impact factor: 4.849
Authors: Elizabeth B Engler-Chiurazzi; Phoebe A Stapleton; Jessica J Stalnaker; Xuefang Ren; Heng Hu; Timothy R Nurkiewicz; Carroll R McBride; Jinghai Yi; Kevin Engels; James W Simpkins Journal: J Toxicol Environ Health A Date: 2016-04-19
Authors: N'Dea S Irvin-Choy; Katherine M Nelson; Megan N Dang; Jason P Gleghorn; Emily S Day Journal: Nanomedicine Date: 2021-06-17 Impact factor: 6.096
Authors: Andrea Adamcakova-Dodd; Martha M Monick; Linda S Powers; Katherine N Gibson-Corley; Peter S Thorne Journal: Part Fibre Toxicol Date: 2015-10-06 Impact factor: 9.400
Authors: Rahim Dad Brohi; Li Wang; Hira Sajjad Talpur; Di Wu; Farhan Anwar Khan; Dinesh Bhattarai; Zia-Ur Rehman; F Farmanullah; Li-Jun Huo Journal: Front Pharmacol Date: 2017-09-05 Impact factor: 5.810
Authors: Tom J Phillips; Hannah Scott; David A Menassa; Ashleigh L Bignell; Aman Sood; Jude S Morton; Takami Akagi; Koki Azuma; Mark F Rogers; Catherine E Gilmore; Gareth J Inman; Simon Grant; Yealin Chung; Mais M Aljunaidy; Christy-Lynn Cooke; Bruno R Steinkraus; Andrew Pocklington; Angela Logan; Gavin P Collett; Helena Kemp; Peter A Holmans; Michael P Murphy; Tudor A Fulga; Andrew M Coney; Mitsuru Akashi; Sandra T Davidge; C Patrick Case Journal: Sci Rep Date: 2017-08-22 Impact factor: 4.379
Authors: Mark R Miller; Jennifer B Raftis; Jeremy P Langrish; Steven G McLean; Pawitrabhorn Samutrtai; Shea P Connell; Simon Wilson; Alex T Vesey; Paul H B Fokkens; A John F Boere; Petra Krystek; Colin J Campbell; Patrick W F Hadoke; Ken Donaldson; Flemming R Cassee; David E Newby; Rodger Duffin; Nicholas L Mills Journal: ACS Nano Date: 2017-04-26 Impact factor: 15.881